We are live on ! Find out more
FCMI

Foresite Capital Management I Portfolio holdings

AUM $21.4M
1-Year Est. Return 80.48%
This Fund
S&P 500
This Quarter Est. Return
+18.6%
1 Year Est. Return
-80.48%
3 Year Est. Return
-40.72%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$103M
AUM Growth
–
Cap. Flow
+$98M
Cap. Flow %
95.2%
Top 10 Hldgs %
100%
Holding
9
New
9
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
KPTI icon
Karyopharm Therapeutics
KPTI
+$29.2M
2
AMBI
Ambit Biosciences Corp
AMBI
+$27.8M
3
KERX
Keryx Biopharmaceuticals Inc
KERX
+$15.7M
4
TLPH icon
Talphera
TLPH
+$12M
5
XNCR icon
Xencor
XNCR
+$7.03M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 79.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KPTI icon
1
Karyopharm Therapeutics
KPTI
$216M
$32.6M 31.69%
+105,716
New +$29.2M
AMBI
2
DELISTED
Ambit Biosciences Corp
AMBI
$20M 19.47%
+2,079,569
New +$27.8M
KERX
3
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$17M 16.5%
+1,312,006
New +$15.7M
TLPH icon
4
Talphera
TLPH
$68.5M
$15.6M 15.15%
+68,954
New +$12M
XNCR icon
5
Xencor
XNCR
$1.3B
$7.5M 7.28%
+820,000
New +$7.03M
NVAX icon
6
Novavax
NVAX
$1.35B
$6.84M 6.65%
+66,810
New +$4.72M
XLRN
7
DELISTED
Acceleron Pharma
XLRN
$2.61M 2.54%
+66,000
New +$1.59M
BDSI
8
CALL
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$720K 0.7%
+2,000
New +$10.3K
NVAX icon
9
PUT
Novavax
NVAX
$1.35B
$16K 0.02%
+325
New +$23K

Similar funds

A
Atlassian San Francisco, California $21M AUM 71.86% 1-Year Est. Return
CVGI
Craft Ventures GP II San Francisco, California $24.1M AUM 83.06% 1-Year Est. Return
AEPI
AH Equity Partners IV Menlo Park, California $24.5M AUM 73.4% 1-Year Est. Return
AGDR
AdamCapital Gestao de Recursos Rio De Janeiro, Brazil $18.1M AUM 32.38% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
WL
WiL LLC Palo Alto, California $17.5M AUM 75.04% 1-Year Est. Return
NVPX
Norwest Venture Partners XIII Palo Alto, California $25.8M AUM 76.52% 1-Year Est. Return
SVGI
Sozo Ventures GP I Redwood City, California $16.3M AUM 66.18% 1-Year Est. Return

Foresite Capital Management I's Q4 2013 Portfolio in Review

Q4 2013 is the first quarter with a 13F filing on record for Foresite Capital Management I, which disclosed 9 positions worth $103M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Karyopharm Therapeutics: 105,716 shares worth $32.6M.

By sector, the portfolio is most concentrated in Healthcare at 80% of assets.

  • Foresite Capital Management I's largest Q4 2013 buy was Karyopharm Therapeutics: 105,716 shares worth $32.6M.
  • Foresite Capital Management I's ten largest holdings make up 100% of its $103M portfolio in Q4 2013.
  • Foresite Capital Management I disclosed 9 positions in Q4 2013, its first 13F filing on record.

Based on Foresite Capital Management I's 13F filing for Q4 2013, filed 14 Feb 2014.